Hims & Hers Health, Inc. (HIMS) call put ratio 1.6 calls to 1 put into quarter results and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Hims and Hers (HIMS) PT Raised to $28 at BofA Securities
May 6, 2025 6:59 AM EDTBofA Securities analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $28.00 (from $26.00) while maintaining a Underperform rating.
The analyst comments "Following this quarters earnings, we see a wider range of outcomes for full year revenue (link to our first take here). In the first scenario, if HIMS were to grow its... More
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS)
May 6, 2025 4:58 AM EDTBofA Securities analyst Michael Cherny reiterated an Underperform rating and $26.00 price target on Hims and Hers (NYSE: HIMS).
The analyst comments "HIMS reported a strong quarter, with revenue of $586MM well ahead of the guidance/consensus and slightly ahead of BofAs estimate of $583.1MM. Second quarter... More
